filings.toolsItem 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
Certain factors may have a material adverse effect on our business, financial condition, results of operations and cash flows, and you should carefully consider them. It is not possible to predict or identify all such factors. For a discussion of potential risks or uncertainties affecting us, please refer to the information under the heading “Item 1A—Risk Factors” in our 2022 Annual Report. Additional risks and uncertainties that are not yet identified or that we currently believe to be immaterial may also materially harm our business, financial condition, results of operations and cash flows.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities:
| (In millions, except number of shares and per share amounts) | |||||||||||||||||||||||
| Period in 2023 | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs (1) | Approximate Dollar Value of Shares that May Yet be Purchased Under the Programs (1) | |||||||||||||||||||
| April 1 - April 30 | — | $ | — | — | $ | 274.5 | |||||||||||||||||
| May 1 - May 31 | — | — | — | 274.5 | |||||||||||||||||||
| June 1 - June 30 | 157,491 | 127.05 | 157,491 | 254.5 | |||||||||||||||||||
| Total | 157,491 | $ | 127.05 | 157,491 | $ | 254.5 |
(1)Shares repurchased pursuant to the May 2021 publicly announced share repurchase authorization of up to $900.0 million aggregate cost at purchase of outstanding common stock. As of June 30, 2023, $254.5 million aggregate cost at purchase remained unused under the repurchase authorization.
Previous: Item 1. Legal Proceedings · Next: Item 5. Other Information